Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced Western brand-name drugs at hospitals, amid a rare public backlash against the government’s drive to cut medical costs.
Hospital chiefs and doctors in Beijing and Shanghai said the cheaper generic drugs mandated for use at public hospitals do not appear to have the same efficacy or side effects as drugs from major international pharmaceutical companies, local media Caixin and China Business News reported over the weekend.
They fear their widespread use risks breeding mistrust among doctors and patients.
Photo: AP
In a proposal to the ongoing annual local parliamentary session, doctors suggest greater flexibility in the nation’s drug-contract bidding process so that doctors and patients can have the choice to switch back to Western brand-name drugs when they want to, local media reported.
The complaints from frontline doctors have prompted the National Healthcare Security Administration, which oversees China’s state medical insurance scheme, to look into the issue.
The agency is to meet with doctors and experts in Shanghai this week to learn more about their advice and collect more clinical data on domestic generic medicines, a statement published on its Web site yesterday said.
Zheng Minhua, a senior surgeon at Shanghai’s prestigious Ruijin Hospital, cited in an interview with Caixin examples of how domestic generic medicines failed to work properly, such as not being able to control hypertension effectively or anesthetics not being able to put patients to sleep.
Since it was launched six years ago, the government’s drug bidding process, known as volume-based procurement, has seen off-patent medicines from global pharmaceutical giants such as AstraZeneca PLC and Pfizer Inc replaced by similar drugs made by domestic companies, often sold at a fraction of the price.
The program has saved Beijing billions of US dollars over the years, which it has then used to reimburse higher-value innovative therapies, including many blockbusters developed by Western drugmakers.
From 2018 to 2023, makers of generic drugs slashed prices by more than 50 percent on average to win contracts, with some cutting as much as 90 percent.
In the most recent round of procurement, the winning bids for generic aspirin tablets were as low as 0.03 yuan (US$0.0041) per pill, while folic acid tablets for pregnant women could be available for just 0.0289 yuan each.
While domestic generics supplied to Chinese hospitals have passed bioequivalence tests that show they work as well as the brand-name medicines, there has been growing chatter among patients and doctors since last year that the quality of these drugs does not quite measure up to the Western ones.
China is set to push for a new procurement round later this year. The rare backlash from doctors is raising questions whether Beijing’s bid to cut drug prices might have come at the expense of quality and might end up fomenting public discontent.
The death of a former head of China’s one-child policy has been met not by tributes, but by castigation of the abandoned policy on social media this week. State media praised Peng Peiyun (彭珮雲), former head of China’s National Family Planning Commission from 1988 to 1998, as “an outstanding leader” in her work related to women and children. The reaction on Chinese social media to Peng’s death in Beijing on Sunday, just shy of her 96th birthday, was less positive. “Those children who were lost, naked, are waiting for you over there” in the afterlife, one person posted on China’s Sina Weibo platform. China’s
‘POLITICAL LOYALTY’: The move breaks with decades of precedent among US administrations, which have tended to leave career ambassadors in their posts US President Donald Trump’s administration has ordered dozens of US ambassadors to step down, people familiar with the matter said, a precedent-breaking recall that would leave embassies abroad without US Senate-confirmed leadership. The envoys, career diplomats who were almost all named to their jobs under former US president Joe Biden, were told over the phone in the past few days they needed to depart in the next few weeks, the people said. They would not be fired, but finding new roles would be a challenge given that many are far along in their careers and opportunities for senior diplomats can
Australian Prime Minister Anthony Albanese yesterday announced plans for a national bravery award to recognize civilians and first responders who confronted “the worst of evil” during an anti-Semitic terror attack that left 15 dead and has cast a heavy shadow over the nation’s holiday season. Albanese said he plans to establish a special honors system for those who placed themselves in harm’s way to help during the attack on a beachside Hanukkah celebration, like Ahmed al-Ahmed, a Syrian-Australian Muslim who disarmed one of the assailants before being wounded himself. Sajid Akram, who was killed by police during the Dec. 14 attack, and
RUSHED: The US pushed for the October deal to be ready for a ceremony with Trump, but sometimes it takes time to create an agreement that can hold, a Thai official said Defense officials from Thailand and Cambodia are to meet tomorrow to discuss the possibility of resuming a ceasefire between the two countries, Thailand’s top diplomat said yesterday, as border fighting entered a third week. A ceasefire agreement in October was rushed to ensure it could be witnessed by US President Donald Trump and lacked sufficient details to ensure the deal to end the armed conflict would hold, Thai Minister of Foreign Affairs Sihasak Phuangketkeow said after an ASEAN foreign ministers’ meeting in Kuala Lumpur. The two countries agreed to hold talks using their General Border Committee, an established bilateral mechanism, with Thailand
RSS